Why CJC-1295 with DAC and materials sold as No DAC must be distinguished analytically.
CJC-1295 is associated with growth-hormone-releasing-hormone analog research. The best-known published CJC-1295 molecule contains a Drug Affinity Complex modification that enables covalent albumin binding and prolonged exposure.
Why No DAC is different
Commercial materials labeled CJC-1295 No DAC are commonly associated with a shorter-acting modified GRF(1-29)-type analog, but naming is not sufficiently standardized to prove sequence. The long-acting CJC-1295 trial literature therefore cannot be transferred automatically to a No DAC vial.
Research interpretation
Growth-hormone-axis readouts can be sensitive to sequence, terminal chemistry, assay timing, and receptor potency. The certificate of analysis should state the complete peptide sequence and molecular mass. Without that information, CJC-1295 No DAC is a catalog name rather than a fully resolved molecular identity.
Primary source for the DAC form
Research-use notice: For laboratory research use only. Not for human or veterinary use, ingestion, injection, therapeutic, diagnostic, or clinical use. This educational material summarizes research context; it is not medical advice and does not establish safety, efficacy, identity, purity, or suitability for any use.